Tag: GAE
Interventional News Issue 96—November 2024 US Edition
Interventional News 96 Highlights:
New research finds that genicular artery embolization (GAE) has a lasting benefit of up to two years for moderate to...
Interventional News Issue 96—November 2024 Edition
Interventional News 96 Highlights:
New research finds that genicular artery embolization (GAE) has a lasting benefit of up to two years for moderate to...
New study shows durability of minimally invasive procedure to combat knee...
A new study shows that a minimally invasive treatment for osteoarthritis (OA) in the knees may have a lasting benefit of at least two...
GAE for mild knee osteoarthritis deemed “safe” with unexpected neuropsychological effect
A new study has determined genicular artery embolization (GAE) to be a “safe intervention” for mild knee osteoarthritis (OA), showing a sustained benefit at...
Interventional News’ top 10 most popular stories of November 2022
Interventional News’ most popular stories last month included news of a US Food and Drug Administration pre-market approval submission of an ultrasound renal denervation...
Varian announces first participant treated in GENESIS II trial of genicular...
Varian, a Siemens Healthineers company, announced today that the first trial participant has been treated as part of GENESIS II, a study of Embozene...
GAE’s growing evidence base broadens scope for future NICE recommendation
Mark Little (Royal Berkshire Hospital, Reading, UK) brought delegates up to speed on genicular artery embolization (GAE) for knee osteoarthritis over two sessions at...
ET 2022 gives airtime to the momentum behind MSK embolotherapy
Mark Little (Royal Berkshire NHS Foundation Trust, Reading, UK) described the emergence of, and advancement within, musculoskeletal (MSK) embolotherapy as “fast-paced” during his presentation...
GAE with Embosphere microspheres comparable long-term results to imipenem cilastatin in...
Trisacryl gelatin microspheres 100–300μm in size can be considered for genicular artery embolization (GAE), a new study presented at the 2021 meeting of the...
GAE “highly effective and durable”, offering long-term pain relief for osteoarthritis...
Genicular artery embolization (GAE) is “highly effective and durable” in reducing symptoms due to moderate-to-severe knee osteoarthritis that is refractory to other conservative therapy...
Preliminary results of first European prospective study find GAE reduces pain...
Geniculate artery embolization (GAE) is responsible for statistically significant improvements in pain scores from baseline out to three months, the preliminary results of the...
Embolization registry will use artificial intelligence to predict patient outcomes
Sandeep Bagla (chair of Interventional Radiology at the Vascular Institute at Virginia, Woodbridge, USA) presented the results of an initial clinical study detailing his...
First geniculate artery embolization in the UK performed
The first geniculate artery embolization (GAE) to take place in the UK to treat osteoarthritis pain in the knee has been performed by Mark...
